https://doi.org/10.5812/asjsm-157974

Rheumatic Disorders and Athletic Achievement: Can Chronic Illness Stop Olympic Dreams?

authors:

avatar Maryam Noury ORCID 1 , 2 , avatar Farzin Halabchi ORCID 3 , * , avatar Vahid Ziaee ORCID 4 , 5

Children’s Medical Center, Pediatric Center of Excellence, Tehran, Iran
Pediatric Rheumatology Society of Iran, Iran
Department of Sports and Exercise Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
Sports Medicine Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
Department of Pediatrics, Tehran University of Medical Sciences, Tehran, Iran
Asian Journal of Sports Medicine: Vol.15, issue 4; e157974
published online: December 28, 2024
article type: Editorial
received: November 19, 2024
revised: December 17, 2024
accepted: December 17, 2024

How To Cite? Noury M, Halabchi F, Ziaee V. Rheumatic Disorders and Athletic Achievement: Can Chronic Illness Stop Olympic Dreams?. Asian J Sports Med. 2024;15(4):e157974. https://doi.org/10.5812/asjsm-157974.

The participation and success of individuals with rheumatic diseases in paralympic competitions are anticipated, but the possibility of engaging in professional sports while managing a rheumatic condition, such as rheumatoid arthritis (RA), remains a topic of debate.

Arian Salimi, an Iranian taekwondo athlete and gold medalist at the 2024 Paris Olympics, was diagnosed with juvenile idiopathic arthritis at the age of three. He experienced recurrent episodes of fever accompanied by arthritis in both knees and also suffered from ophthalmic problems such as anterior chamber involvement and uveitis. X-ray images showed bilateral knee joint inflammation with periarticular osteopenia, and his laboratory tests revealed a positive result for fluorescent antinuclear antibody (FANA). After receiving medical treatment, his symptoms were effectively controlled. He began exercising, and today, he is an Olympic gold medalist.

There is substantial evidence supporting the numerous health benefits of physical activity and exercise for individuals with RA, including improvements in joint health, physical function, mobility, and psychological well-being. Additionally, these activities help alleviate rheumatoid cachexia and fatigue without worsening symptoms or causing further joint damage (1-3).

Despite the well-documented benefits of physical activity, studies show that patients with RA are significantly less active than healthy individuals. Systematic reviews indicate that 71% of RA patients do not engage in regular physical activity, falling short of recommended levels (4-6). A recent randomized controlled trial revealed that although a cognitive-behavioral education program increased patients' intent to be physically active, it did not result in a change in their actual activity levels. These findings suggest that RA patients may face unique or more significant barriers to physical activity compared to the general population (7, 8).

Both quantitative and qualitative research clearly identify pain and fatigue as the primary arthritis-related barriers to regular physical activity. Other disease-related challenges include reduced mobility, functional limitations, and stiffness, all of which impede engagement in physical exercise (9-13). In addition to these physical challenges, qualitative studies also highlight issues such as the lack of specialized exercise programs for individuals with arthritis and a general lack of understanding regarding suitable exercise routines, which negatively impact physical activity levels (12).

The concerns regarding appropriate exercise for RA patients are often linked to fears of worsening the condition or causing joint damage. Moreover, patients frequently report that healthcare providers do not offer sufficient guidance on which exercises are appropriate for managing RA (14).

Current RA management typically involves disease-modifying drugs and biological agents, which can significantly reduce disease activity and structural damage. However, challenges remain, as some patients continue to struggle with achieving clinical remission or maintaining low disease activity levels. Non-pharmacological treatments, especially exercise therapy, have proven to be effective in alleviating symptoms and improving daily functioning in RA patients, and they have also been shown to reduce disease activity and severity (15-18).

Although many believe that RA poses a barrier to achieving athletic success, several individuals have shown that this is, in fact, a misconception. Arian Salimi is one example of this. Dina Rios, who was diagnosed with RA in 2008, faced severe distress upon her diagnosis. As a competitive runner, her training was significantly impacted during her first year of college due to persistent foot pain, which remained despite extensive rest. After consulting numerous doctors and undergoing multiple evaluations, she was ultimately diagnosed with RA. Despite setbacks, including two hip replacements and wrist surgery, Dina continued to pursue her passion for running. Initially, she could only manage a slow pace for 800 meters, which was both painful and discouraging. However, her persistence paid off, and she eventually competed in 5Ks, 10Ks, and two half marathons before transitioning to triathlons, which were less strenuous on her body. In 2015, she reached a major milestone by qualifying for and participating in her first USA Triathlon National Championship.

Jeri Strachner is another athlete with RA who has continued to compete in sports at a high level. Many athletes around the world are managing rheumatic disorders while still excelling in their respective fields, proving that these conditions do not necessarily prevent professional athletic participation.

In conclusion, rheumatic diseases should not be viewed as a barrier to exercise or athletic achievement. The experiences of individuals like Arian Salimi, Dina Rios, and others demonstrate that rheumatic conditions do not hinder professional athletic success. The main difference between Arian Salimi and the other two athletes is that Arian Salimi achieved success after the disease completely subsided, while the others were successful while struggling with the disease and its complications, including joint replacement. Therefore, it is crucial to challenge the belief that RA or other rheumatic diseases prevent individuals from reaching their full athletic potential.

References

  • 1.

    Cooney JK, Law RJ, Matschke V, Lemmey AB, Moore JP, Ahmad Y, et al. Benefits of exercise in rheumatoid arthritis. J Aging Res. 2011;2011:681640. [PubMed ID: 21403833]. [PubMed Central ID: PMC3042669]. https://doi.org/10.4061/2011/681640.

  • 2.

    Summers GD, Metsios GS, Stavropoulos-Kalinoglou A, Kitas GD. Rheumatoid cachexia and cardiovascular disease. Nat Rev Rheumatol. 2010;6(8):445-51. [PubMed ID: 20647995]. https://doi.org/10.1038/nrrheum.2010.105.

  • 3.

    Metsios GS, Stavropoulos-Kalinoglou A, Sandoo A, van Zanten JJ, Toms TE, John H, et al. Vascular function and inflammation in rheumatoid arthritis: the role of physical activity. Open Cardiovasc Med J. 2010;4:89-96. [PubMed ID: 20361002]. [PubMed Central ID: PMC2847820]. https://doi.org/10.2174/1874192401004020089.

  • 4.

    Law RJ, Markland DA, Jones JG, Maddison PJ, Thom JM. Perceptions of issues relating to exercise and joint health in rheumatoid arthritis: a UK-based questionnaire study. Musculoskeletal Care. 2013;11(3):147-58. [PubMed ID: 23125122]. https://doi.org/10.1002/msc.1037.

  • 5.

    Henchoz Y, Zufferey P, So A. Stages of change, barriers, benefits, and preferences for exercise in RA patients: a cross-sectional study. Scand J Rheumatol. 2013;42(2):136-45. [PubMed ID: 23244196]. https://doi.org/10.3109/03009742.2012.724707.

  • 6.

    Tierney M, Fraser A, Kennedy N. Physical activity in rheumatoid arthritis: a systematic review. J Phys Act Health. 2012;9(7):1036-48. [PubMed ID: 22971883]. https://doi.org/10.1123/jpah.9.7.1036.

  • 7.

    Sokka T, Hakkinen A, Kautiainen H, Maillefert JF, Toloza S, Mork Hansen T, et al. Physical inactivity in patients with rheumatoid arthritis: data from twenty-one countries in a cross-sectional, international study. Arthritis Rheum. 2008;59(1):42-50. [PubMed ID: 18163412]. https://doi.org/10.1002/art.23255.

  • 8.

    John H, Hale ED, Treharne GJ, Kitas GD, Carroll D. A randomized controlled trial of a cognitive behavioural patient education intervention vs a traditional information leaflet to address the cardiovascular aspects of rheumatoid disease. Rheumatology (Oxford). 2013;52(1):81-90. [PubMed ID: 22942402]. https://doi.org/10.1093/rheumatology/kes237.

  • 9.

    Gyurcsik NC, Brawley LR, Spink KS, Brittain DR, Fuller DL, Chad K. Physical activity in women with arthritis: examining perceived barriers and self-regulatory efficacy to cope. Arthritis Rheum. 2009;61(8):1087-94. [PubMed ID: 19644901]. https://doi.org/10.1002/art.24697.

  • 10.

    Hutton I, Gamble G, McLean G, Butcher H, Gow P, Dalbeth N. Obstacles to action in arthritis: a community case-control study. Int J Rheum Dis. 2009;12(2):107-17. [PubMed ID: 20374327]. https://doi.org/10.1111/j.1756-185X.2009.01392.x.

  • 11.

    Brittain DR, Gyurcsik NC, McElroy M, Hillard SA. General and arthritis-specific barriers to moderate physical activity in women with arthritis. Womens Health Issues. 2011;21(1):57-63. [PubMed ID: 20833069]. https://doi.org/10.1016/j.whi.2010.07.010.

  • 12.

    Law RJ, Breslin A, Oliver EJ, Mawn L, Markland DA, Maddison P, et al. Perceptions of the effects of exercise on joint health in rheumatoid arthritis patients. Rheumatology (Oxford). 2010;49(12):2444-51. [PubMed ID: 20871130]. https://doi.org/10.1093/rheumatology/keq299.

  • 13.

    Kaptein SA, Backman CL, Badley EM, Lacaille D, Beaton DE, Hofstetter C, et al. Choosing where to put your energy: a qualitative analysis of the role of physical activity in the lives of working adults with arthritis. Arthritis Care Res (Hoboken). 2013;65(7):1070-6. [PubMed ID: 23335584]. https://doi.org/10.1002/acr.21957.

  • 14.

    Loeppenthin K, Esbensen B, Ostergaard M, Jennum P, Thomsen T, Midtgaard J. Physical activity maintenance in patients with rheumatoid arthritis: a qualitative study. Clin Rehabil. 2014;28(3):289-99. [PubMed ID: 24013270]. https://doi.org/10.1177/0269215513501526.

  • 15.

    Boers M, van Tuyl L, van den Broek M, Kostense PJ, Allaart CF. Meta-analysis suggests that intensive non-biological combination therapy with step-down prednisolone (COBRA strategy) may also 'disconnect' disease activity and damage in rheumatoid arthritis. Ann Rheum Dis. 2013;72(3):406-9. [PubMed ID: 23155223]. https://doi.org/10.1136/annrheumdis-2012-202333.

  • 16.

    Weinblatt ME. Methotrexate in rheumatoid arthritis: a quarter century of development. Trans Am Clin Climatol Assoc. 2013;124:16-25. [PubMed ID: 23874006]. [PubMed Central ID: PMC3715949].

  • 17.

    Conigliaro P, Triggianese P, De Martino E, Fonti GL, Chimenti MS, Sunzini F, et al. Challenges in the treatment of Rheumatoid Arthritis. Autoimmun Rev. 2019;18(7):706-13. [PubMed ID: 31059844]. https://doi.org/10.1016/j.autrev.2019.05.007.

  • 18.

    Weijers JM, Rongen-van Dartel SAA, Hoevenaars D, Rubens M, Hulscher M, van Riel P. Implementation of the EULAR cardiovascular risk management guideline in patients with rheumatoid arthritis: results of a successful collaboration between primary and secondary care. Ann Rheum Dis. 2018;77(4):480-3. [PubMed ID: 29167154]. https://doi.org/10.1136/annrheumdis-2017-212392.